These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Preliminary observations on the treatment of Schistosomiasis mansoni with praziquantel in Kenya.
    Author: Smith DH, Highton RB, Roberts JM.
    Journal: Arzneimittelforschung; 1981; 31(3a):594-6. PubMed ID: 7195253.
    Abstract:
    In the past three months 2-cyclo-hexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one (praziquantel, EMBAY 8440, Biltricide) has been used in Kenya in the treatment of schistosomiasis mansoni at a single oral dose of 40 mg/kg. To date 42 individuals have been treated and one month follow-up data on egg excretion is available on 22. Whilst trivial side effects were relatively common (50%), the drug proved highly acceptable to the community studied. Vomiting occurred in 7%. Preliminary analysis of mean egg excretion suggests a 99.1% reduction in geometric mean egg excretion, three to four weeks following treatment. If these encouraging preliminary results are confirmed, Biltricide appears to fulfil many of the criteria for a community treatment of schistosomiasis mansoni in endemic areas.
    [Abstract] [Full Text] [Related] [New Search]